HALO logo
halo search icon
CHM
Chimeric Therapeutics Limited

CHM · Chimeric Therapeutics Limited

0.019

AUD
-0.016 (-45.714%)
19/08/2026 04:10:13 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

AU$1.16M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Franking

0%

MQV Rating

5Very Weak

As at 19/08/2026 04:10:13 PM

Price Chart

Description

Chimeric Therapeutics Ltd. is a clinical stage cell therapy company, which engages in the development and commercialization of cell therapies in oncology. Its products include NK Cell Derived Allogenic Therapies and T Cell Derived Autologous Therapies. The company was founded by Paul A. Hopper in 2020 and is headquartered in Carlton South, Australia.

  • All-Companies
  • Big Candle
  • GROWTH AUS
  • HALO Ords
  • Hammer Bullish
  • Near 52 Week Low
  • Near Support

Key Fundamentals

EPS 3 yr Growth

-81.60%

EBITDA Margin

-446.70%

Operating Cashflow

-$7m

Free Cash Flow Return

-327.40%

ROIC

-469.40%

Interest Coverage

N/A

Quick Ratio

0.70

Performance

52 weeks range

Low 0.01 - 0.4

Trade Value (12mth)

AU$5,089.00

1 week

-14.63%

1 month

-20.45%

YTD

-88.33%

1 year

-88.33%

All time high

40.39

Additional Data

Shares Outstanding (Fully Diluted)

33m

HALO Sector

Healthcare

Next Company Report Date

28-Aug-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
19 August 26ASXD
17 August 26ASXD
07 August 26ASXD
31 July 26ASXD
29 July 26ASXD

Key Stakeholders

NameTitle
GKCC LLCPrivate Company

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Chimeric Therapeutics Limited (CHM:ASX)?
Halo FAQ
The current share price of Chimeric Therapeutics Limited (CHM:ASX) is AUD$0.02.
2
What is the 52-week high share price for Chimeric Therapeutics Limited (CHM:ASX)?
Halo FAQ
The 52-week high share price for Chimeric Therapeutics Limited (CHM:ASX) is AUD$0.40.
3
What is the 52-week low share price for Chimeric Therapeutics Limited (CHM:ASX)?
Halo FAQ
The 52-week low share price for Chimeric Therapeutics Limited (CHM:ASX) is AUD$0.01.
4
What is the dividend yield for Chimeric Therapeutics Limited (CHM:ASX)?
Halo FAQ
Chimeric Therapeutics Limited (CHM:ASX) does not pay a dividend.
5
What was Chimeric Therapeutics Limited (CHM:ASX) last dividend payment?
Halo FAQ
Chimeric Therapeutics Limited (CHM:ASX) does not pay a dividend.
6
What is the franking level for Chimeric Therapeutics Limited (CHM:ASX)?
Halo FAQ
Chimeric Therapeutics Limited (CHM:ASX) has a franking level of 0.00%.
7
In which sector is Chimeric Therapeutics Limited (CHM:ASX) classified?
Halo FAQ
Chimeric Therapeutics Limited (CHM:ASX) is classified in the Healthcare.